| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |